Package 21130-593-79

Brand: naproxen sodium

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 21130-593-79
Digits Only 2113059379
Product NDC 21130-593
Product ID 21130-593_e8a8e1bb-2989-4193-b172-4d2a6c33d9b7
Description

400 TABLET, FILM COATED in 1 BOTTLE (21130-593-79)

Marketing

Marketing Status
Marketed Since 2025-08-13
Brand naproxen sodium
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

NAPROXEN SODIUM ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e8a8e1bb-2989-4193-b172-4d2a6c33d9b7", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["849574"], "spl_set_id": ["396f4e60-3dde-433f-b4b5-25f351c96d57"], "manufacturer_name": ["Safeway"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "400 TABLET, FILM COATED in 1 BOTTLE (21130-593-79)", "package_ndc": "21130-593-79", "marketing_start_date": "20250813"}], "brand_name": "NAPROXEN SODIUM", "product_id": "21130-593_e8a8e1bb-2989-4193-b172-4d2a6c33d9b7", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "21130-593", "generic_name": "Naproxen Sodium", "labeler_name": "Safeway", "product_type": "HUMAN OTC DRUG", "brand_name_base": "NAPROXEN SODIUM", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA074661", "marketing_category": "ANDA", "marketing_start_date": "20250813", "listing_expiration_date": "20261231"}